FDA News Digest for August 18, 2008

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA News Digest for August 18, 2008

---

Important Notice for FDA News Digest Subscribers

 

This issue of FDA News Digest is the last in the current format. But you can still receive the same information through the GovDelivery subscription management system. With it, you can subscribe to the FDA subject areas that interest you.

 

To continue to receive the same information that was in the News Digest, go to the area(s) of your interest:

 

FDA news items -- https://service.govdelivery.com/service/subscribe.html?code=USFDA_53

Safety alerts/recalls -- https://service.govdelivery.com/service/subscribe.html?code=USFDA_48

Consumer health information -- https://service.govdelivery.com/service/subscribe.html?code=USFDA_9

 

To see the full listing of free FDA information available by e-mail through the GovDelivery system, go to http://www.fda.gov/emaillist.html.

 

Thanks to all of you for your interest in FDA News Digest over the last eight years. We hope it has been a useful resource for you and that you continue to receive FDA information through the GovDelivery system.

---

FDA News Digest

August 18, 2008

_____________________________________

 

IN THIS WEEK'S ISSUE

 

»  News

    -- First Drug Approved to Treat Involuntary Movement in Huntington’s Disease

»  Safety Alerts/Recalls

»  Upcoming Public Meetings

»  Consumer Health Information

__________________________________________

NEWS

 

First Drug Approved to Treat Involuntary Movement in Huntington’s Disease

FDA has approved Xenazine (tetrabenazine) to treat chorea in people with Huntington’s disease. Chorea is the jerky, involuntary movement that occurs in people with this disease. Xenazine is the first treatment of any kind approved in the United States for any symptom of Huntington’s disease. Serious side effects reported with use of Xenazine include depression and suicidal thoughts and actions. Xenazine should not be used in patients who are actively suicidal or in patients with untreated depression. 

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01874.html 

 

To view an archive of recent FDA news releases, go to

http://www.fda.gov/opacom/hpnews.html.

   

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

_____________________________________________

 

SAFETY ALERTS/RECALLS

 

For a complete list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html. 

 

To access the RSS feed of FDA recalls information, go to

http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml  

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]  

____________________________________________________________________

 

UPCOMING PUBLIC MEETINGS

 

Sept. 8-10 -- Parenteral Drug Association (PDA)/FDA Joint Regulatory Conference

    Location: Washington, D.C.

http://www.pda.org/webmodules/webarticles/templates/new_conferences_2008_PDA_FDA.aspx?articleid=1453&zoneid=190

 

Sept. 10-12 -- Parenteral Drug Association (PDA)/FDA Pharmaceutical Ingredient Supply Chain Conference

    Location: Washington, D.C.

http://www.pda.org/webmodules/webarticles/templates/2008_PDA-FDA_Pharmaceutical_Ingredient_Supply_Chain_Conference.aspx?articleid=1803&zoneid=233

 

For a complete list of upcoming meetings, seminars, and other public events sponsored

or co-sponsored by FDA, go to http://www.fda.gov/opacom/hpmeetings.html.

 

 

CONSUMER HEALTH INFORMATION

 

Consumer updates in the spotlight this week are:

 

› FDA Law Enforcers Crack Down on Illegal Botox Scammers

http://www.fda.gov/consumer/updates/botox081308.html

› Potential Problem at Two Baltimore Pharmacies

http://www.fda.gov/consumer/updates/baltimorepharmacies081108.html

 

To receive all consumer updates by e-mail, go to http://www.fda.gov/consumer/consumerenews.html.

For the latest in consumer health news from FDA, visit http://www.fda.gov/consumer/default.htm. 

 

 

Check out "Andy's Take," a commentary from FDA's commissioner.

Go to http://www.fda.gov/oc/vonEschenbach/andys_take/default.html

_____________________________________________________________

 

Thanks for subscribing to FDA News Digest. It's been a great eight years!

To continue receiving FDA news and information in your e-mailbox, go to

http://www.fda.gov/emaillist.html. 

 

    Comments about FDA News Digest?

    Send an e-mail to fdanewsdigest@xxxxxxxxxv.  

 

 

---

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420